ConductScience.org, home

Gene · 6607

NIH grants1,484

NIH grants whose papers are about the gene, through NIH's grant-paper links.

881 to 900 of 1,484

Download this page as JSON
GrantTitleSMN2 papersNewest fiscal year
R00DK099434The role of DNA damage response signaling in chronic kidney disease12017
R00GM110121Mechanisms controlling phosphoinositide synthesis at the plasma membrane12017
R01AG043540SMART HAND12017
R01AG046949LGP/Longenity12017
R01CA103867E2-Cellular Complexes in HPV Chromatin Transcription12017
R01CA167516HuR Targeted Nanotherapy for Lung Cancer12017
R01EY024747Ataxin-7 oligonucleotide knock-down to treat SCA7 retinal and cerebellar disease12017
R01GM040282Analysis of Admixture and Range Expansion in Humans and Extinct Hominims12017
R01GM048430Greatwall Kinase and the Mitotic Control of Phosphatase Activity12017
R01GM090278Polycomb complexes targeted to specific loci by long noncoding RNA cofactors.12017
R01GM109146Regulation of mRNA isoform fate12017
R01GM109199Functional Profiling of Human Disease Targets12017
R01HG008133Predicting the causative SNPs in LD blocks by allele-specific structural analysis12017
R01HL121358NGS in Large CAD Families: In-Depth Identification of Rare Risk Genomic Variants12017
R01MH104284Deconstructing Psychoses Based on Patterns of Abnormal Brain Activity12017
R01MH104680Integration of brain imaging with genomic and epigenomic data12017
R01NS036126Nanomedicine and NeuroAIDS12017
R01NS080820Gene discovery in PSP by transcriptome, neuropathology and sequence analysis12017
R01NS081208Antisense RNA Mediated Epigenetic Regulation of Brain Derived Neurotrophic Factor12017
R01NS085207ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models12017

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/6607/grants?page=45